Amylyx Pharmaceuticals (AMLX) Cash & Equivalents (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) recorded Cash & Equivalents of $49.33 million in Q2 2026, down 15.1% from $58.09 million a year earlier and down 78.5% from the prior quarter.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Amylyx Pharmaceuticals reported Cash & Equivalents of $226.65 million, up 192.9% from FY2024.
- Annual Cash & Equivalents has a four-year compound annual growth rate of 45.8% (FY2021 to FY2025).
- Across earlier years, Cash & Equivalents came in at $77.39 million in FY2024 (-54.5%), $170.2 million in FY2023 (+172.2%), $62.53 million in FY2022 (+24.6%) and $50.19 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Cash & Equivalents in data going back to Q4 2021.
- On a year-over-year basis, Cash & Equivalents rose in three of the last eight quarters, with growth averaging 60.7%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 283.4% in Q1 2026, against a decline of 69.7% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $229.14 million (Q1 2026), $226.65 million (Q4 2025) and $225.18 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Amylyx Pharmaceuticals | 3.24 Bn | 3.24 Bn | - | 49.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.33 Mn |
| Mar 31, 2026 | 229.14 Mn |
| Dec 31, 2025 | 226.65 Mn |
| Sep 30, 2025 | 225.18 Mn |
| Jun 30, 2025 | 58.09 Mn |
| Mar 31, 2025 | 59.76 Mn |
| Dec 31, 2024 | 77.39 Mn |
| Sep 30, 2024 | 71.84 Mn |
| Jun 30, 2024 | 75.00 Mn |
| Mar 31, 2024 | 170.55 Mn |
| Dec 31, 2023 | 170.20 Mn |
| Sep 30, 2023 | 135.26 Mn |
| Jun 30, 2023 | 247.76 Mn |
| Mar 31, 2023 | 114.56 Mn |
| Dec 31, 2022 | 62.53 Mn |
| Sep 30, 2022 | 107.73 Mn |
| Jun 30, 2022 | 67.44 Mn |
| Mar 31, 2022 | 110.40 Mn |
| Dec 31, 2021 | 50.19 Mn |
API Access
Amylyx Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AMLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AMLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AMLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();